Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Brainstorm Cell Therapeutics Inc. (BCLI)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Sabby Capital

Hal Mintz

1,010,682 $3,588 +12% 0.78%
2. 0 $0 0%
3. 0 $0 0%
4. 10,867 $39 0%
5. 182,457 $648 +37% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$3.39 1,475 Director 7,175 2019-01-04 Filing
$3.50 5,700 Director 5,700 2018-03-15 Filing
$3.60 5,000 Officer 40,885 2018-03-15 Filing
$4.26 2,500 Director 155,833 2017-08-31 Filing
$3.98 2,000 Officer, Director 7,543 2017-08-23 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$2.71 10,800 Director 28,399 2015-12-16 Filing
$2.57 5,000 Director 0 2015-12-14 Filing
$2.59 11,263 Director 8,666 2015-12-15 Filing
$2.61 30,479 Director 19,929 2015-12-14 Filing
$2.56 5,300 Director 39,199 2015-12-11 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 206 $89 0%
2. 22 $9 0%
3. 4,484 $19 0%
4. 3,500 $15 0%
5. 557 $2 0%
News See All